Presbyopia Clinical Trial
Official title:
Performance Evaluation of Different Daily Disposable Multifocal Contact Lenses
Verified date | March 2023 |
Source | Coopervision, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of the study is to compare the lens performance of two daily disposable multifocal contact lenses.
Status | Completed |
Enrollment | 60 |
Est. completion date | June 15, 2023 |
Est. primary completion date | June 15, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 42 Years and older |
Eligibility | Inclusion Criteria: - Is at least 42 years of age and has full legal capacity to volunteer; - Has read and signed an information consent letter; - Self reports having a full eye examination in the previous two years; - Anticipates being able to wear the study lenses for at least 8 hours a day, 5 days a week; - Is willing and able to follow instructions and maintain the appointment schedule; - Habitually wears multifocal soft contact lenses, for the past 3 months minimum^; - Maximum of 7 participants per site should be habitual wearers of daily disposable lenses - Maximum of 3 habitual wearers per site of 1-Day Acuvue Moist Multifocal - Maximum of 1 habitual wearer per site of ACUVUE OASYS MAX 1-Day MULTIFOCAL - Maximum of 3 habitual wearers per site of MyDay Multifocal - Maximum of 7 participants per site should be habitual wearers of frequent replacement lenses - Maximum of 1 habitual wearer per site of ACUVUE OASYS for PRESBYOPIA - Has refractive astigmatism no higher than -0.75DC; - Is presbyopic and requires a reading addition of at least +0.75D and no more than +2.50D; - Can be fit and achieve binocular distance vision of at least 20/30 Snellen (or +0.20 logMAR) which participants also deem to be 'acceptable', with the available study lens parameters (Distance sphere +4 to -6; near addition as per study design). Exclusion Criteria: - Is participating in any concurrent clinical or research trial; - Has any known active* ocular disease and/or infection that contraindicates contact lens wear; - Has a systemic condition that in the opinion of the investigator may affect a study outcome variable; - Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable; - Has known sensitivity to the diagnostic sodium fluorescein used in the study; - Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment; - Has undergone refractive error surgery or intraocular surgery. |
Country | Name | City | State |
---|---|---|---|
Canada | Eyes on Sheppard Clinic | Toronto | Ontario |
Canada | Spadina Optometry | Toronto | Ontario |
United States | Athens Eye Care- Dr. Shane Foster & Associates | Athens | Ohio |
United States | Bellaire Family Eye Care | Bellaire | Texas |
United States | Sacco Eye Group PLLC | Vestal | New York |
Lead Sponsor | Collaborator |
---|---|
Coopervision, Inc. | CORE |
United States, Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Lens Handling for Removal | Lens Handling for Removal, using a 0-100 scale (0=Very difficult, 100=Very easy) | 2 weeks of wear |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05326607 -
Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia
|
N/A | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Completed |
NCT05495971 -
Extended Depth of Focus Contact Lenses for Presbyopia
|
N/A | |
Completed |
NCT05464732 -
Vivity IOL: Emmetropia Compared to Monovision.
|
N/A | |
Recruiting |
NCT06045299 -
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
|
Phase 3 | |
Active, not recruiting |
NCT04151550 -
Safety & Efficacy of the Laser Scleral Microporation Procedure (Philippines)
|
N/A | |
Not yet recruiting |
NCT05506553 -
Comparison of Aspheric Toric Intraocular Lenses for Micro-monovision
|
N/A | |
Completed |
NCT02554396 -
Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
|
Phase 2 | |
Completed |
NCT02214797 -
Dispensing Study to Assess Visual Performance of Prototype Contact Lenses
|
N/A | |
Completed |
NCT02235831 -
DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance
|
N/A | |
Enrolling by invitation |
NCT01443585 -
Clinical Evaluation of a Progressive Addition Lens (PAL)
|
N/A | |
Completed |
NCT01591499 -
Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal
|
N/A | |
Completed |
NCT04983589 -
A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily
|
Phase 3 | |
Completed |
NCT02740010 -
The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus
|
||
Recruiting |
NCT05796453 -
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
|
N/A | |
Completed |
NCT02516306 -
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
|
Phase 1/Phase 2 | |
Completed |
NCT05359380 -
The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living
|
||
Not yet recruiting |
NCT04522427 -
Study of Presbyopia-correcting Intraocular Lenses in Eyes With Previous Corneal Refractive Surgery
|
N/A | |
Completed |
NCT03688425 -
Comparison of Clinical Outcomes POD L GF vs POD F GF in Asian Eyes
|
N/A | |
Recruiting |
NCT06053463 -
Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers
|
N/A |